تكلم مع الذكاء الاصطناعي
Deck 33: Treatment of Obesity and Eating Disorders
ملء الشاشة (f)
سؤال
سؤال
سؤال
فتح الحزمة
قم بالتسجيل لفتح البطاقات في هذه المجموعة!
Unlock Deck
Unlock Deck
1/3
العب
ملء الشاشة (f)
Deck 33: Treatment of Obesity and Eating Disorders
Sibutramine has which of the following actions?
A) Decreases appetite
B) Decreases thermogenic physiologic pathways
C) Decreases high-density lipoprotein levels
D) Decreases heart rate
E) Decreases blood pressure
A) Decreases appetite
B) Decreases thermogenic physiologic pathways
C) Decreases high-density lipoprotein levels
D) Decreases heart rate
E) Decreases blood pressure
Decreases appetite
The sympathomimetic anti-obesity agents:
A) Are chemically related to norepinephrine and dopamine
B) Include phentermine and orlistat
C) Inhibit GI lipase
D) Have their effect primarily through speeding up metabolism
E) Are Schedule II medications
A) Are chemically related to norepinephrine and dopamine
B) Include phentermine and orlistat
C) Inhibit GI lipase
D) Have their effect primarily through speeding up metabolism
E) Are Schedule II medications
Are chemically related to norepinephrine and dopamine
Which of the following can be used to stimulate appetite in patients with cachexia?
A) Dronabinol
B) Corticosteroids
C) Progestational agents
D) A and B
E) A, B, and C
A) Dronabinol
B) Corticosteroids
C) Progestational agents
D) A and B
E) A, B, and C
A, B, and C
فتح الحزمة
افتح القفل للوصول البطاقات البالغ عددها 3 في هذه المجموعة.
